BeStock  
Markets › Compare › BEAM vs VRTX

BEAM vs VRTX

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
BEAM · Beam Therapeutics$20.90 ▼ 0.19%
VRTX · Vertex Pharmaceuticals$515.02 ▼ 1.08%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

83104124144165Nov 24, '25May 26, '26Nov 20, '26
  • BEAM -11.5%
  • VRTX +21.5%

Head to head

MetricBEAMVRTX
Price$20.90$515.02
Change today▼ 0.19%▼ 1.08%
Market cap$2.16B$130.58B
Return, 3 months-26.2%-5.9%
Return, year to date-24.6%+13.6%
Return, 1 year-5.9%+20.7%
P/E (TTM)–33.1
P/B2.36.2
P/E percentile vs own 5y15th99th
Dividend yield––
Revenue growth (YoY, latest qtr)-96.8%+11.8%
Net profit growth (YoY)-19.4%-39.6%
Gross margin–85.5%
Operating margin-267.7%33.1%
Net margin-73.9%30.7%
Return on equity-11.3%20.8%
Analyst target vs. price+136.2%+21.1%
Analyst buy share92%95%
RSI (14)3641
30-day volatility76.9%32.0%
Max drawdown, 1 year-45.5%-15.2%
Trend readStrong downtrendLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • VRTX is the largest of the group by market value.
  • VRTX has returned the most over the past year.
  • VRTX is growing revenue fastest.
  • VRTX keeps the most profit per dollar of sales.
  • VRTX has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top